No profile data available.
Daxor Corporation (DXR) is a healthcare company in the targeted healthcare equipment industry, based in Oak Ridge, United States.
It reported revenue of $10.30 million for fiscal year 2025, up 383.5% from fiscal year 2024, and net income of $9.17 million. Its market capitalization was $60.78 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Daxor reported $10.30 million in revenue for fiscal year 2025, up 383.5% from $2.13 million in fiscal year 2024.
$60.78 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Outset Medical, Inc. (OM), RetinalGenix Technologies Inc. (RTGN), Microbot Medical Inc. (MBOT), Medinotec Inc. (MDNC).